Sahar Lotfi-Emran
Overview
Explore the profile of Sahar Lotfi-Emran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castro-Pearson S, Samorodnitsky S, Yang K, Lotfi-Emran S, Ingraham N, Bramante C, et al.
Sci Rep
. 2024 Jul;
14(1):16370.
PMID: 39014194
No abstract available.
2.
Thomas C, Zubair T, Monteagudo L, Lotfi-Emran S, Yamanuha J
J Vitreoretin Dis
. 2024 Mar;
8(2):181-185.
PMID: 38465357
To highlight clinical and imaging features of 5 patients diagnosed with retinal vasculitis and cryoglobulins. This retrospective case series describes clinical and angiographic features of retinal vasculitis and serum cryoglobulins...
3.
Yang K, Kang Z, Guan W, Lotfi-Emran S, Mayer Z, Guerrero C, et al.
Metabolites
. 2023 Nov;
13(11).
PMID: 37999202
Metabolic disease is a significant risk factor for severe COVID-19 infection, but the contributing pathways are not yet fully elucidated. Using data from two randomized controlled trials across 13 U.S....
4.
Castro-Pearson S, Samorodnitsky S, Yang K, Lotfi-Emran S, Ingraham N, Bramante C, et al.
Sci Rep
. 2023 Nov;
13(1):20315.
PMID: 37985892
Significant progress has been made in preventing severe COVID-19 disease through the development of vaccines. However, we still lack a validated baseline predictive biologic signature for the development of more...
5.
Gavil N, Scott M, Weyu E, Smith O, OFlanagan S, Wijeyesinghe S, et al.
Sci Immunol
. 2023 Jun;
8(84):eadd5976.
PMID: 37267383
Analyses of healthy tissue reveal signatures that identify resident memory CD8 T cells (T), which survey tissues without recirculating. The density of T phenotype cells within solid tumors correlates favorably...
6.
Stolley J, Scott M, Joag V, Dale A, Johnston T, Saavedra F, et al.
J Exp Med
. 2023 Apr;
220(7).
PMID: 37097449
The oral mucosa is a frontline for microbial exposure and juxtaposes several unique tissues and mechanical structures. Based on parabiotic surgery of mice receiving systemic viral infections or co-housing with...
7.
Rosato P, Lotfi-Emran S, Joag V, Wijeyesinghe S, Quarnstrom C, Degefu H, et al.
Mucosal Immunol
. 2023 Jan;
16(1):17-26.
PMID: 36657662
Adaptive immunity is didactically partitioned into humoral and cell-mediated effector mechanisms, which may imply that each arm is separate and does not function together. Here, we report that the activation...
8.
Lusczek E, Ingraham N, Karam B, Proper J, Siegel L, Helgeson E, et al.
PLoS One
. 2021 Mar;
16(3):e0248956.
PMID: 33788884
Purpose: Heterogeneity has been observed in outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19). Identification of clinical phenotypes may facilitate tailored therapy and improve outcomes. The purpose of this...
9.
Karam B, Morris R, Bramante C, Puskarich M, Zolfaghari E, Lotfi-Emran S, et al.
J Med Virol
. 2020 Dec;
93(4):1843-1846.
PMID: 33314219
In this commentary, we shed light on the role of the mammalian target of rapamycin (mTOR) pathway in viral infections. The mTOR pathway has been demonstrated to be modulated in...
10.
Lusczek E, Ingraham N, Karam B, Proper J, Siegel L, Helgeson E, et al.
medRxiv
. 2020 Sep;
PMID: 32995813
Background: There is limited understanding of heterogeneity in outcomes across hospitalized patients with coronavirus disease 2019 (COVID-19). Identification of distinct clinical phenotypes may facilitate tailored therapy and improve outcomes. Objective:...